CompletedPhase 2NCT03041012

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Aarhus University Hospital
Principal Investigator
Ole S Søgaard, MD PhD
Aarhus University Hospital
Intervention
Romidepsin(drug)
Enrollment
60 enrolled
Eligibility
18 years · All sexes
Timeline
2017 – 2022

Study locations (7)

Collaborators

Rigshospitalet, Denmark · Hvidovre University Hospital · Odense University Hospital · Aalborg University Hospital · Herning Hospital · Hammersmith Hospitals NHS Trust · St Mary's Hospital, London

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03041012 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency →

← Back to all trials